Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2008-04-08
2008-04-08
Witherspoon, Sikarl A. (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
C562S450000, C514S562000, C514S563000
Reexamination Certificate
active
07355069
ABSTRACT:
The present invention provides a compound of formula (I), wherein n is 0, 1 or 2 and R1represents halo, a C1-4alkyl group which is optionally substituted by one or more fluoro, a C1-4alkoxy group which is optionally substituted by one or more fluoro and wherein when n is 2 the substituents R1may be the same or different; R2represents a C2-8alkyl group which is optionally interrupted by oxygen; Y is absent or represents methylene; and X is O or S; and pharmaceutically acceptable salts and prodrugs thereof, to processes for preparing such compounds, to their utility in treating clinical conditions associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them
REFERENCES:
patent: 4113871 (1978-09-01), Stach et al.
patent: 5750783 (1998-05-01), Goldmann et al.
patent: 6258850 (2001-07-01), Andersson
patent: 6306854 (2001-10-01), Brown et al.
patent: 6906058 (2005-06-01), Starke et al.
patent: 7125864 (2006-10-01), Starke et al.
patent: 7132416 (2006-11-01), Starke et al.
patent: 7192945 (2007-03-01), Starke et al.
patent: 7192946 (2007-03-01), Starke et al.
patent: 7192947 (2007-03-01), Starke et al.
patent: 7226943 (2007-06-01), Starke et al.
patent: 7238684 (2007-07-01), Starke et al.
patent: 2002/0022656 (2002-02-01), Per Sauerberg et al.
patent: 2005/0222261 (2005-10-01), Li
patent: 2005/0267149 (2005-12-01), Li
patent: 0 802 186 (1997-10-01), None
patent: 1 184 366 (2002-03-01), None
patent: 99/20275 (1999-04-01), None
patent: 99/32477 (1999-07-01), None
patent: 00/64876 (2000-11-01), None
patent: 00/64888 (2000-11-01), None
patent: 01/12187 (2001-02-01), None
patent: WO 01/66533 (2001-09-01), None
patent: WO 02/32428 (2002-04-01), None
patent: WO 02/50051 (2002-06-01), None
patent: WO 03/020710 (2003-03-01), None
patent: WO 03/022286 (2003-03-01), None
patent: WO 03/022825 (2003-03-01), None
patent: WO 03/022830 (2003-03-01), None
patent: WO 03/05821 (2003-06-01), None
patent: WO 03/051822 (2003-06-01), None
patent: WO 03/051826 (2003-06-01), None
patent: WO 03/091232 (2003-11-01), None
patent: 2004/000294 (2003-12-01), None
patent: 2004/000295 (2003-12-01), None
patent: WO 03/106482 (2003-12-01), None
patent: WO 04/000294 (2003-12-01), None
patent: WO 04/000295 (2003-12-01), None
patent: WO 04/056748 (2004-06-01), None
patent: WO 04/110984 (2004-12-01), None
patent: WO 04/110985 (2004-12-01), None
patent: WO 04/113276 (2004-12-01), None
patent: WO 04/113282 (2004-12-01), None
patent: WO 04/113283 (2004-12-01), None
patent: WO 04/113284 (2004-12-01), None
patent: WO 04/113285 (2004-12-01), None
Astrazeneca AB
Morgan & Lewis & Bockius, LLP
Witherspoon Sikarl A.
LandOfFree
Ortho-substituted benzoic acid derivatives for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ortho-substituted benzoic acid derivatives for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ortho-substituted benzoic acid derivatives for the treatment... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2756541